Search Results - Yangmi Lim
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release by Eunhee Lee, Yong-Gyu Son, Shinai Lee, Yangmi Lim, Jonghwa Won, Sumyeong Park, Jiseon Yoo, Youngil Koh, Dong-Yeop Shin
Published in Journal for ImmunoTherapy of Cancer (2023-10-01)Get full text
Article -
8
CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia by Boris Klimovich, Boris Klimovich, Leonard Anton, Jinwon Jung, Yangmi Lim, Bora Lee, Jonghwa Won, Latifa Zekri, Latifa Zekri, Anna Chashchina, Anna Chashchina, Martin Pflügler, Jonas S. Heitmann, Jonas S. Heitmann, Gundram Jung, Helmut R. Salih, Helmut R. Salih
Published in Frontiers in Immunology (2025-03-01)Get full text
Article -
9
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade by Lei Fang, Wenqing Jiang, Zhengyi Wang, Su-Hyung Park, Eui-Cheol Shin, Minwoo Jeon, Jaeho Jung, Hyunjoo Kim, Hyung-Don Kim, Shin Hwang, Seongju Jeong, Eunyoung Park, Eunsil Sung, Jaehyoung Jeon, Youngkwang Kim, Ui-jung Jung, Yong-Gyu Son, Youngeun Hong, Hanbyul Lee, Shinai Lee, Yangmi Lim, Jonghwa Won
Published in Journal for ImmunoTherapy of Cancer (2021-07-01)Get full text
Article
